
SAN · NYSE
Banco Santander is a Spain-headquartered international bank that provides banking and financial services to personal and business customers. It earns revenue from banking activities including net interest income, which rose 10% in the first nine months of 2026. The available evidence identifies Europe, the United States and Latin America as important operating regions; Latin America contributes around 45% of earnings, while Morningstar describes the bank’s historical returns in Europe and the US as comparatively subscale. Santander reported €46.8 billion of nine-month total revenue, €11.2 billion of underlying profit and record attributable profit of €12.405 billion for the period. The supplied information does not give revenue or profit by business segment.
Santander fell 8.91%, from $12.90 to $11.75, over the quoted week. Shares dropped to $12.37 on Monday, made a small recovery to $12.47 Tuesday, then slid to $11.69 Wednesday before edging up Thursday. The sharpest decline came on Wednesday, when coverage reported that third-quarter EPS of $0.26 and revenue of $17.8 billion missed estimates. That disappointment weighed against underlying profit growth: Q3 underlying profit rose 19% year over year to about €3.8 billion, while attributable profit fell 2%. The bank also reported record nine-month attributable profit of €12.405 billion and reiterated its 2026 targets, but those positives did not prevent the midweek selloff. The supplied evidence does not establish a broader market driver.
SAN fell 3.41%, from $13.48 to $13.02, over the supplied weekly interval. Shares rose to $13.55 on Oct. 13, then slipped to $13.41 the next day, recovered slightly to $13.46 on Oct. 15, and declined to $13.30 on Oct. 16 before dropping to $13.02 on Oct. 19. The evidence does not identify a company-specific event that explains the decline. J.P. Morgan raised its Banco Santander target on Oct. 15, but the snippet gives no evidence that the change drove trading in the ADR; an Oct. 28 results call was also announced. No market-index or sector data is supplied to establish broader-market context.
Banco Santander’s ADR fell 3.02%, from $13.90 to $13.48, over the reported week. It rose to $14.01 on October 6, then reversed, dropping to $13.66 on October 7 and $13.48 on October 8; it was nearly unchanged on October 9 and October 12. The supplied company-specific notices concern a 6.1 million-share buyback purchase and redemption of 4.750% preferred securities with ECB approval, but the evidence gives no dates or indication that either drove the share-price moves. No company-specific catalyst in the evidence explains the decline. Reuters described a broader market backdrop of an AI rally wobbling as investors’ focus turned to earnings, though it did not connect that context directly to Santander.
SAN fell 1.27% over the reported week, from $14.19 to $14.01, but the path was a sharp early decline followed by a rebound. Shares dropped to $13.28 on October 1, then edged to $13.36 on October 2 before jumping to $13.90 on October 5 on 20.9 million shares; they added to $14.01 on October 6. The supplied evidence does not establish a catalyst for either leg and provides no broad-market benchmark. A Stock Titan report says Santander repurchased 21.6 million shares from October 1–7 and had used more than half its buyback budget, but does not link the purchases to the daily price moves.
SAN fell $1.00, or 7.00%, over the stated week, from $14.28 to $13.28. It closed at $14.22 on Monday and $14.19 on Tuesday, then weakened to $13.83 on Wednesday and dropped a further 4.12% to $13.28 on Thursday, with Thursday also the week’s highest reported volume at 10.2 million shares. The supplied evidence does not identify a company-specific announcement or a broader market catalyst for the decline. TradingKey’s October 1 article reports analyst targets and profit figures, but its supplied snippet does not establish either as the cause of that day’s move. The available evidence therefore leaves the week’s selling without a substantiated catalyst.
SAN fell 1.39%, from $14.40 to $14.20. The supplied evidence does not identify a company-specific event that explains the decline or provide broad-market returns for comparison. Trading was choppy: after closing at $14.31 on Friday, September 18, the ADR rose to $14.62 on Monday, September 21, then retreated to $14.20 by Wednesday, September 23; volume peaked at 8.7 million shares on Tuesday. Headlines cited a $34% undervaluation thesis tied to Santander’s Chile investment plan and a buyback that had purchased 10.9 million shares in seven days, using 38.2% of its limit, but the evidence does not date those items clearly enough to link them to the week’s price moves. Citi raised its euro price target on September 18, before the week began.
SAN rose 2.06% over the supplied week, from $14.56 to $14.86. Trading was volatile: the stock slipped to $14.38, rebounded to $14.75 and then $15.05, before giving back part of the advance to close at $14.93 and later $14.86. The principal company-specific development in the evidence was coverage of Santander’s capital-return program, including €469 million of share repurchases and claims that 18% of shares had already been cancelled. That reporting may have supported sentiment, but the evidence does not establish a direct price reaction. No other company-specific catalyst or broad-market benchmark was supplied to explain the week.
SAN rose $0.50, or 3.44%, from $14.55 to $15.05 over the reported period. The stock was little changed at $14.56 on Monday, fell to $14.38 on Tuesday, then reversed higher, gaining $0.37 on Wednesday and another $0.30 on Thursday. The evidence does not identify a dated company-specific catalyst for the advance. Company-related coverage highlighted Santander’s €305.9 million buyback expenditure, the redemption of 1.722% 2027 notes, completion of the Webster Financial acquisition with new shares, and an institutional purchase by Nwam LLC, but it does not establish that any drove this week’s trading. Reuters instead reported a broader Wall Street rebound, providing the clearest market context.
SAN rose $0.08, or 0.55%, from $14.59 to $14.67 over the week. The stock gained $0.13 on Monday to $14.72, then gave back most of that advance on Tuesday before recovering on Wednesday. Thursday brought the week's largest reversal, a $0.15 decline to $14.55, followed by a $0.12 rebound on Friday. The only company-specific item in the supplied news was Santander's reported issuance of $2 billion of senior notes due between 2030 and 2034, but the evidence does not establish that it drove trading. With no reported financials or other clear catalyst, the modest net move appears largely market-driven; the Nasdaq 100 indicator was down on Monday, although SAN still rose that day.
Banco Santander ADRs rose 1.66% over the week, from $14.45 to $14.69. Trading was quiet on Monday and Tuesday before a material Wednesday advance to $14.64, accompanied by 28.9 million shares, followed by smaller gains on Thursday and Friday. The strongest company-specific catalysts were reports of shareholder returns, including a proposed EUR1.8 billion buyback tied to 2026 earnings and reports that a larger multi-billion-euro repurchase was nearing completion. The market also received Federal Reserve approval for Santander’s acquisition of Webster Financial. The stock gave back $0.01 on August 10, but did not reverse the prior gains. No reported financials or additional operating news were supplied, so the evidence does not establish a broader earnings-driven move.
SAN rose 3.51%, from $13.98 to $14.47, despite a sharp mid-period reversal. The stock fell to $13.38 on July 29 before rebounding to $14.11 on July 30, then held near $14.10 on July 31 and gained again to $14.45 and $14.47 on August 3-4. The clearest company-specific support in the supplied evidence was RBC Capital’s July 28 price-target increase to EUR13.50 from EUR12.75, alongside a reported Buy view. Morgan Stanley also raised its target to EUR13.80 from EUR13.50, although the timing is not specified. No new financials or definitive operating catalyst were supplied, so the week’s later strength appears to have reflected supportive analyst sentiment rather than a fully documented corporate announcement.